Convexity Labs

TRMK

Convexity Analyst · TRMK
Buymedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: TRMK (Trustmark Corporation)

Date: 2026-06-20 Subject: Structural Setup & Business Fundamentals Review

1. Structural Readiness

  • State: Actionable (Per user input)
  • Conservative Entry: Not yet defined (awaiting breakout confirmation).
  • Aggressive/Pre-Breakout Entry: Not defined in data.
  • Breakout Level: Not defined in data.
  • Current Price: $44.67.
  • Extension: Not defined in data.
  • ATR Context: Current ATR is 2.2% (Sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting a tighter, potentially slower-moving setup if a breakout occurs.

2. Thesis Layer

  • Thesis Classification: Tactical / Setup-Led
  • Analysis: As of 2026-06-20, there is no named secular thesis attached to this setup. The investment case is not driven by a macro narrative (e.g., "AI Infrastructure Boom" or "Rate Cut Cycle") but is strictly a function of the technical structure (Price-Break) combined with the underlying business fundamentals. The conviction must be derived entirely from the quality of the setup formation and the strength of the financials, without the tailwind of a named macro theme.

3. The Business

  • Company Overview: Trustmark Corporation (TRMK) operates as a regional bank holding company. Its primary subsidiary, Trustmark Bank, provides a full range of commercial banking services to corporations and business customers.
  • Business Model: The firm generates revenue through net interest income (lending) and non-interest income (fees, mortgage production). It maintains a dominant local franchise, ranking within the top three deposit market shares in 52.0% of its 56 served counties and top five in 68.0% of those counties as of June 30, 2025.
  • Key Fundamentals (Source: Q1 2026 Earnings & Filings):
  • Loan Growth: Loans held for investment (LHFI) totaled $13.878 billion as of March 31, 2026, an increase of $203.7 million (1.5%) quarter-over-quarter and $636.5 million (4.8%) year-over-year. Management expects loans to increase single digits for the full year 2026.
  • Deposit Base: Total deposits reached $15.713 billion, up $212.7 million (1.4%) QoQ. Excluding brokered deposits, deposits are expected to grow mid-single digits for the full year. The cost of total deposits was 1.63% in Q1, a 9 basis point decrease from the prior quarter.
  • Net Interest Margin (NIM): NIM-FTE for Q1 2026 was 3.81%, up 6 basis points YoY. Management anticipates the full-year 2026 NIM to be in the range of 3.80% to 3.85%.
  • Mortgage Production: Mortgage loan production for Q1 2026 was $375.1 million, a 17.7% increase YoY.
  • Capital Return: The Board authorized $100 million in share repurchases for 2026. A quarterly cash dividend of $0.25 per share was declared on April 28, 2026.
  • Credit Quality: Management expects the total provision for credit losses to normalize in 2026. The loan portfolio is described as well-diversified by type and geography.

4. Archetype and Conviction

  • Archetype: Quality Compounder
  • *Fit:* The company demonstrates consistent, organic growth in both loans and deposits without reliance on volatile brokered funding. The ability to grow NIM (3.81% in Q1) while managing deposit costs (1.63%) suggests a pricing power and balance sheet efficiency characteristic of a compounder. The diversified loan book and strong local market share (top 3 in >50% of counties) provide a defensive moat.
  • Conviction Stack:
  • Thesis Strength: Low (Tactical only; no macro tailwind).
  • Evidence Quality: High. The Q1 2026 data shows robust growth across all key metrics (Loans +4.8% YoY, Deposits +4.2% YoY, NIM expansion).
  • Rerating Potential: Moderate. The combination of mid-single-digit growth expectations and normalized credit provisions supports a steady valuation, but the lack of a named secular thesis limits the multiple expansion potential compared to high-growth tech or cyclical plays.

5. Invalidations, Strengths, and Gaps

  • What Would Invalidate:
  • A significant deterioration in credit quality (provision spikes) or a sharp contraction in loan demand contrary to management's "single digit" guidance.
  • A failure to maintain the NIM within the 3.80%-3.85% guidance range.
  • What Would Strengthen:
  • Continued acceleration in mortgage production or commercial loan growth beyond the single-digit guidance.
  • Successful execution of the $100M buyback program, reducing share count.
  • Evidence Gaps:
  • Macro Context: While the 2025 10-K mentions "mixed signals" and "tariffs," the specific impact of the "geopolitical shock" mentioned in the Q1 2026 filing on the bank's specific loan book is not detailed in the provided evidence.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Q1 2026 loan growth of 4.8% YoY and deposit growth of 4.2% YoY; NIM expansion to 3.81% with management guidance of 3.80-3.85% for full year; dominant local market share (top 3 in 52% of counties). Expected path: Management expects mid-single digit growth in loans and deposits with normalized credit provisions; price likely consolidates in the forming coil range until a breakout triggers. Expected horizon: 3 to 6 months for the structural setup to resolve (breakout or invalidation).

Loading chart...
Exhibit 1: TRMK daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for TRMK.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for TRMK.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: